STOCK TITAN

ICON Announces Appointment of Chief Operating Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

ICON plc (NASDAQ: ICLR) has appointed Barry Balfe as Chief Operating Officer (COO). Balfe, a 20-year veteran of the company, has served in various leadership roles across full service and functional solutions. He will continue to report to CEO Steve Cutler.

The appointment leverages Balfe's extensive experience in operational excellence, quality, and delivery. His track record includes successfully leading ICON's largest division and developing strategic customer partnerships that have contributed to the company's growth. In his new role, Balfe will focus on driving further organizational growth and enhancing ICON's position as a healthcare intelligence partner.

ICON plc (NASDAQ: ICLR) ha nominato Barry Balfe come Chief Operating Officer (COO). Balfe, veterano dell'azienda con 20 anni di esperienza, ha ricoperto vari ruoli di leadership in soluzioni complete e funzionali. Continuerà a riferire al CEO Steve Cutler.

La nomina sfrutta l'ampia esperienza di Balfe nell'eccellenza operativa, qualità e consegna. Il suo percorso include la guida con successo della più grande divisione di ICON e lo sviluppo di partnership strategiche con i clienti che hanno contribuito alla crescita dell'azienda. Nel suo nuovo ruolo, Balfe si concentrerà sulla promozione della crescita organizzativa e sul miglioramento della posizione di ICON come partner nell'intelligence sanitaria.

ICON plc (NASDAQ: ICLR) ha nombrado a Barry Balfe como Director de Operaciones (COO). Balfe, un veterano de la empresa con 20 años de experiencia, ha ocupado varios cargos de liderazgo en soluciones completas y funcionales. Continuará reportando al CEO Steve Cutler.

La designación aprovecha la amplia experiencia de Balfe en excelencia operativa, calidad y entrega. Su historial incluye la dirección exitosa de la división más grande de ICON y el desarrollo de asociaciones estratégicas con los clientes que han contribuido al crecimiento de la empresa. En su nuevo rol, Balfe se centrará en impulsar un mayor crecimiento organizativo y en mejorar la posición de ICON como socio en inteligencia sanitaria.

ICON plc (NASDAQ: ICLR)가 Barry Balfe를 최고 운영 책임자 (COO)로 임명했습니다. Balfe는 20년 경력의 베테랑으로, 전방위 서비스 및 기능 솔루션에서 다양한 리더십 역할을 수행해왔습니다. 그는 계속해서 CEO Steve Cutler에게 보고할 것입니다.

이번 임명은 운영 우수성, 품질 및 제공에 대한 Balfe의 폭넓은 경험을 활용하게 됩니다. 그의 경력에는 ICON의 가장 큰 부서를 성공적으로 이끌고, 회사의 성장에 기여한 전략적 고객 파트너십을 개발한 경험이 포함되어 있습니다. 그의 새로운 역할에서 Balfe는 조직의 추가 성장 추진 및 ICON의 헬스케어 인텔리전스 파트너로서의 위치 강화를 목표로 할 것입니다.

ICON plc (NASDAQ: ICLR) a nommé Barry Balfe au poste de Directeur des opérations (COO). Balfe, un vétéran de l'entreprise avec 20 ans d'expérience, a occupé divers postes de leadership dans des solutions complètes et fonctionnelles. Il continuera à rendre compte au PDG Steve Cutler.

Cette nomination tire parti de l'énorme expérience de Balfe en matière d'excellence opérationnelle, de qualité et de livraison. Son parcours comprend la direction réussie de la plus grande division d'ICON et le développement de partenariats clients stratégiques ayant contribué à la croissance de l'entreprise. Dans son nouveau rôle, Balfe se concentrera sur la promotion de la croissance organisationnelle et le renforcement de la position d'ICON en tant que partenaire en intelligence sanitaire.

ICON plc (NASDAQ: ICLR) hat Barry Balfe zum Chief Operating Officer (COO) ernannt. Balfe, ein 20-jähriger Veteran des Unternehmens, hat in verschiedenen Führungspositionen in umfassenden und funktionalen Lösungen gedient. Er wird weiterhin an CEO Steve Cutler berichten.

Die Ernennung nutzt Balfe's umfangreiche Erfahrung in operativer Exzellenz, Qualität und Lieferung. Sein Erfolgsbilanz umfasst die erfolgreiche Leitung der größten Sparte von ICON und die Entwicklung strategischer Partnerschaften mit Kunden, die zum Wachstum des Unternehmens beigetragen haben. In seiner neuen Rolle wird Balfe sich darauf konzentrieren, das organisatorische Wachstum weiter voranzutreiben und ICONs Position als Partner für Gesundheitsintelligenz zu stärken.

Positive
  • Appointment of experienced internal candidate with 20+ years at the company
  • Proven track record in leading ICON's largest division
  • Strong history of developing strategic customer partnerships
  • Demonstrated success in operational excellence and delivery
Negative
  • None.

DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today announced the appointment of Barry Balfe as Chief Operating Officer (COO).

Barry is a long-tenured ICON employee with over 20 years of service and brings extensive leadership experience and capability to the role of COO. He has held a number of leadership roles across both full service and functional solutions at ICON and has very successfully supported the growth of new and existing customer partnerships. His strong focus and track record on operational excellence, quality & delivery will enable the company to deliver greater value to our customers and further enhance our strategy to become the healthcare intelligence partner of choice in the industry.

Barry will continue to report to ICON’s Chief Executive Officer, Steve Cutler.

“Barry is a vastly experienced leader and has a very strong reputation across the industry,” said Steve Cutler, ICON’s CEO. “He has successfully led our largest division over the past number of years, creating and sustaining strategic partnerships with customers that have been key to our growth trajectory as a company. I look forward to working closely with Barry to drive further growth across the organisation, as we create value for our customers in delivering their clinical development programs more efficiently.”

“It is a privilege to serve as ICON’s Chief Operating Officer,” said Barry Balfe. “I look forward to working with all of our dedicated colleagues around the world as we continue to drive superior innovation, execution and delivery for customers and for patients.”

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 42,250 employees in 106 locations in 55 countries as at September 30, 2024. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-F

Kate Haven Vice President Investor Relations +1 888 381 7923

All at ICON

Source: ICON plc

FAQ

Who is ICON's new Chief Operating Officer (COO) in 2024?

Barry Balfe has been appointed as ICON plc's (ICLR) new Chief Operating Officer. He is a 20-year veteran of the company with extensive leadership experience across full service and functional solutions.

What experience does Barry Balfe bring to the COO role at ICON (ICLR)?

Barry Balfe brings over 20 years of experience at ICON, having held various leadership roles across full service and functional solutions, including successfully leading the company's largest division and developing strategic customer partnerships.

Who will Barry Balfe report to as ICON's new COO?

As ICON's new Chief Operating Officer, Barry Balfe will continue to report to Steve Cutler, ICON's Chief Executive Officer.

What are the key responsibilities of ICON's new COO appointment?

The new COO will focus on driving organizational growth, delivering greater value to customers, enhancing ICON's strategy as a healthcare intelligence partner, and maintaining operational excellence, quality, and delivery standards.

Icon Plc

NASDAQ:ICLR

ICLR Rankings

ICLR Latest News

ICLR Stock Data

17.00B
81.85M
0.66%
101.13%
1.55%
Diagnostics & Research
Healthcare
Link
United States of America
Dublin